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Abstract
Background: The prevalence of obese and overweight patients has increased dramatically worldwide. Both are
common risk factors for chronic kidney disease (CKD) as indicated by a diminished estimated glomerular filtration
rate (eGFR) or microalbuminuria. This study aimed to investigate whether anthropometric parameters [waist
circumference (WC), waist-to-height ratio (WHtR) and body mass index (BMI)] are associated with renal function in a
population-based study of Caucasian subjects.
Methods: Data from 3749 subjects (1825 women) aged 20 to 81 years from the Study of Health in Pomerania (SHIP)
were analysed. Renal indices, including the urinary albumin-to-creatinine ratio (uACR), microalbuminuria, eGFR and
CKD, were studied. Parameters of anthropometry (WC, WHtR and BMI) were categorised into sex-specific quintiles.
Results: Analysis of variance (ANOVA) models, adjusting for age, sex, type 2 diabetes mellitus and hypertension, revealed
that a high and low WC or WHtR and low BMI were independently related to a higher uACR. Logistic regression models
confirmed these results with respect to uACR and showed that subjects with a high or low WC or a high WHtR had
increased odds of microalbuminuria. The ANOVA models revealed no relations of the investigated anthropometric
parameters with eGFR. However, subjects with high values for these parameters had increased odds of CKD.
Conclusions: Our results demonstrate U-shaped associations between markers of central fat distribution and uACR or
microalbuminuria in the general population, suggesting that both obese and very thin subjects have a higher risk of
renal impairment.
Keywords: Anthropometry, Chronic kidney disease, Estimated glomerular filtration rate, Microalbuminuria, Study of
Health in Pomerania, Urinary albumin-to-creatinine ratio
Background
Chronic kidney disease (CKD) is a global public health
problem with an increasing incidence and prevalence,
poor outcomes and high cost [1]. The prevalence of
recognized CKD among subjects in the U.S. national
social insurance program Medicare increased three-fold
between 2000 and 2009, from 2.7 to 8.5% [2]. In most
patients, CKD is silent and commonly not detected until
an advanced stage [3]. Being overweight [body mass
index (BMI) 25–30 kg/m2] and obesity (BMI >30 kg/m2)
represent major risk factors for renal dysfunction [4,5].
Several studies [6-9] have shown that obesity is a risk
factor for a diminished glomerular filtration rate (GFR)
and CKD. Data from the Framingham Heart Study [7]
revealed that BMI is a strong predictor for developing
CKD. A retrospective case–control study [8] confirmed
these findings and indicated that young overweight
subjects had a three-fold higher risk of stage 5 CKD than
lean control subjects.
Moreover, waist circumference (WC) and waist-to-hip
ratio (WHR) as indices of visceral obesity have been
reported to be even more sensitive predictors of late-stage
renal disease than BMI [6]. Data from the Prevention of
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Renal and Vascular End-Stage Disease (PREVEND) study
[9] revealed that obese subjects with a central fat distri-
bution had a higher risk of microalbuminuria than lean
subjects with a peripheral fat distribution. Furthermore,
that study [9] showed that not only overweight and obese
subjects but also lean subjects with central fat distribution
were at a higher risk of a diminished GFR.
This study aimed to identify possible associations
between WC, WHtR or BMI and renal dysfunction based
on the urinary albumin-to-creatinine ratio (uACR),




The Study of Health in Pomerania (SHIP) is a
population-based cohort study in West Pomerania, a
region in northeastern Germany. Details on the SHIP
design, recruitment and procedures have been published
elsewhere [10]. Baseline data collection started in
October 1997 and was finished in March 2001. The
initial sample for the baseline examination consisted of
4308 participants (net response: 69%). All of the partici-
pants gave written informed consent. The study confor-
med to the principles of the Declaration of Helsinki as
reflected by an a priori approval by the Ethics Committee
of the University of Greifswald. Data usage for the project
(number: SHIP/2011/50/D) was approved by the Research
Network of Community Medicine and the manuscript
was approved by the Publication Committee.
Of the 4308 participants, the 527 subjects with missing
values for serum creatinine, urinary creatinine or serum
albumin were excluded. Furthermore, 12 pregnant women
and 20 subjects with missing values for anthropometric
parameters or certain confounding factors were excluded.
Altogether, the final study population included 3749
subjects (1924 men; 1825 women) aged 20 to 81 years.
Data collection
Information on age, sex, sociodemographic characteris-
tics and medical history was collected using computer-
assisted personal interviews. The definition of type 2
diabetes mellitus was based on a self-reported physician
diagnosis or use of an antidiabetic medication [anatomic,
therapeutic and chemical (ATC) code: A10] during the
last 7 days. After a five-minute resting period, systolic
and diastolic blood pressures were measured three times
on the right arm of seated subjects, using a digital blood
pressure monitor (HEM-705CP, Omron Corporation,
Tokyo, Japan). Each reading was followed by another
rest period of three minutes. The mean of the second
and third measurements was used for the statistical
analyses. Hypertension was defined as systolic blood
pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg
or self-reported use of antihypertensive medication.
Height was measured to the nearest 1 cm using a
digital ultrasound instrument, and weight was measured
to the nearest 0.1 kg in light clothing and without shoes
using standard digital scales (Soehnle-Waagen GmbH,
Nassau, Germany). WC was measured to the nearest
0.1 cm using an inelastic tape midway between the lower
rib margin and the iliac crest in the horizontal plane,
with the subject standing comfortably with weight
distributed evenly on both feet. The WHtR was calcu-
lated as the waist circumference in centimetres divided
by the height in centimetres. The BMI was calculated as
the weight in kilograms divided by the square of height
in metres.
Non-fasting blood and urine samples were collected
between 7.00 a.m. and 6.00 p.m. Blood samples were
taken from the cubital vein of subjects in the supine
position and prepared for immediate analysis or for sto-
rage at −80°C for further analysis. Serum creatinine was
measured using the Jaffé method (Hitachi 717; Roche
Diagnostics, Mannheim, Germany). Urinary creatinine
and albumin concentrations were determined using a
Behring Nephelometer (Siemens BN albumin; Siemens
Healthcare, Marburg, Germany) and a Hitachi 717 device
(Roche Diagnostics), respectively. The uACR was calcu-
lated using the following equation: uACR (mg/mmol) =
urinary albumin concentration (mg/L)/urinary creatinine
concentration (mmol/L). Microalbuminuria was defined
as an uACR ≥2.5 mg/mmol in men or ≥3.5 mg/mmol in
women [11].
The eGFR was calculated using the four-variable
Modification of Diet in Renal Disease (MDRD) study equa-
tion: eGFR = 186.3 * serum creatinine-1.154 * age-0.203 *
(0.742 if female) [1,12]. CKD was defined as an eGFR
<60 mL/min/1.73 m2, consistent with the definition of
CKD ≥ stage 3 proposed by the National Kidney
Foundation Kidney Disease Outcomes Quality Initia-
tive (KDOQI) [1].
Statistical analyses
Continuous data are expressed as the median (25th;
75th quartile) and nominal data are expressed as a
percentage. For bivariate comparisons between women
and men for the baseline characteristics of the study
population, the Kruskal-Wallis test (continuous data) or
the χ2-test (nominal data) was used. As a first step,
linear regression with restricted cubic splines [13] was
used to detect the possible dependency of eGFR or
uACR on WC, WHtR or BMI. Three knots were pre-
specified, located at the 5th, 50th and 95th percentile, as
recommended by Stone and Koo [13], and the uACR
values were log-transformed. Based on these results, the
WC, WHtR and BMI values were categorised into five
Dittmann et al. BMC Nephrology 2013, 14:87 Page 2 of 7
http://www.biomedcentral.com/1471-2369/14/87
groups according to sex-specific quintiles of distribution
(Additional file 1: Table S1).
Next, analysis of variance (ANOVA) models were used
to test for differences in the uACR or eGFR among sex-
specific quintiles of WC, WHtR or BMI. Logistic regres-
sion models were performed to assess the associations
between parameters of anthropometry and microalbu-
minuria or CKD. All models were adjusted for age, sex,
type 2 diabetes mellitus and hypertension. Furthermore,
we tested whether age or sex had a potential effect on
our ordinal regression models, and no significant inter-
action (p < 0.10) between age and the tested variable
was found. Regarding the interaction between sex and
the tested variable, only one out of six models detected a
significant interaction (WHtR and microalbuminuria).
Therefore, we decided not to perform age- or sex-
stratified analyses. Sensitivity analyses were performed
after excluding subjects with type 2 diabetes mellitus or
subjects who died within the first 5 years of follow up.
Adjusted means and odds ratios (ORs) with 95% confi-
dence intervals (CIs) were calculated. A p-value <0.05
was considered to be statistically significant. Statistical




In our study population, the men were older and more
often had hypertension than the women (Table 1).
Regarding anthropometric parameters, the men were
taller and had higher values for weight, WC, WHtR and
BMI than the women. With respect to kidney function,
the men more often had microalbuminuria and a higher
eGFR, and less often had CKD, albeit they had higher
serum creatinine concentrations than the women.
Urinary albumin-to-creatinine ratio and estimated
glomerular filtration rate
First, linear regression models with restricted cubic
splines revealed U-shaped associations between WC,
WHtR or BMI and the uACR or eGFR (Figure 1,
left panels). Multivariable ANOVA models confirmed
these U-shaped relationships between WC or WHtR and
uACR (Figure 1, upper right panel). Specifically, subjects
in the lowest and highest WC and WHtR sex-specific
quintiles had up to 0.29 mg/mmol higher uACRs than
the subjects in the middle quintile. With respect to BMI,
only subjects within the lowest group had higher uACRs
than the remaining groups (uACRs in the lowest and
highest BMI groups were 1.79 mg/mmol and 1.56 mg/
mmol, respectively). No associations were detected
between the investigated anthropometric parameters and
eGFR (Figure 1, lower right panel).
Microalbuminuria and chronic kidney disease
Logistic regression models were performed to assess the
associations between anthropometric parameters and
microalbuminuria or CKD. The analyses confirmed the
U-shaped association between WC and microalbuminuria
(Table 2). Subjects with a high or low WC had up to a
52% increased odds of microalbuminuria compared to the
subjects in the middle quintile WC group. Furthermore, a
high WHtR was related to increased odds of microalbu-
minuria, whereas the relationship between a low WHtR
Table 1 Characteristics of the study population
Characteristics Men (n = 1924) Women (n = 1825) p-value
Age (years) 52 (37; 65) 49 (35; 62) <0.01
Type 2 diabetes mellitus (%) 8.8 8.1 0.42
Hypertension (%) 62.9 41.8 <0.01
Weight (kg) 83.9 (75.8; 92.7) 68.8 (60.9; 79.1) <0.01
Height (cm) 175 (170; 180) 163 (158; 167) <0.01
Waist circumference (cm) 95.5 (87.5; 103.0) 81.5 (73.0; 92.1) <0.01
WHtR 0.55 (0.50; 0.60) 0.50 (0.44; 0.57) <0.01
BMI (kg/m2) 27.4 (24.9; 30.0) 26.2 (22.8; 30.2) <0.01
Serum creatinine (mg/dL) 1.02 (0.94; 1.11) 0.87 (0.80; 0.94) <0.01
Urinary albumin (mg/L) 8.5 (4.8; 18.3) 7.2 (3.9; 14.5) <0.01
Urinary creatinine (mmol/L) 10.0 (6.8; 13.8) 6.7 (4.1; 10.3) <0.01
uACR (mg/mmol) 0.83 (0.51; 1.87) 1.06 (0.66; 2.00) <0.01
Microalbuminuria (%) 19.3 14.5 <0.01
eGFR (mL/min/1.73 m2) 83.24 (73.92; 93.00) 74.81 (66.66; 84.46) <0.01
CKD (%) 6.5 11.4 <0.01
BMI = body mass index; CKD = chronic kidney disease; eGFR = estimated glomerular filtration rate; uACR = urinary albumin-to-creatinine ratio;
WHtR = waist-to-height ratio.
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and microalbuminuria was not statistically significant.
With respect to CKD, subjects in the highest quintiles for
WC, WHtR or BMI exhibited up to 83% increased odds
of CKD compared to subjects in the middle quintile
group. No relationship was found between low anthropo-
metric parameters and CKD.
Our main results were confirmed in several sensitivity
analyses after excluding all subjects with type 2 diabetes
mellitus (316 subjects), subjects who died within the first
5 years of follow-up, which indicates critical illness (259
subjects), or subjects with sample collection after noon
(1037 subjects, Additional file 1: Table S2). Furthermore,
HDL-cholesterol and total cholesterol were tested as
further confounders (Additional file 1: Tables S3 and S4).
All these analyses confirmed the main results and showed
U-shaped associations between the considered anthropo-
metric parameters and uACR as well as a positive relation
between anthropometry and CKD.
Discussion
In this study, we observed associations between three
different parameters of anthropometry and uACR or
microalbuminuria. Both a low and high WC, WHtR and
BMI positively correlated with the uACR. Furthermore,
a high or low WC and a high WHtR were associated
with increased odds of microalbuminuria. In contrast to
the uACR, no association between any of the considered
anthropometric parameters and eGFR was detected.
However, subjects with high anthropometric values had
higher odds of stage 3 CKD than subjects with average
values.
In a previous study [14], obesity was related to an
increased albumin excretion rate. Interestingly, in obese
subjects with the same percentage of total body fat, the
risk of abnormal albumin excretion was 18 times higher
in those with central obesity but only four times higher
in subjects with peripheral obesity compared to controls
[14]. The PREVEND study [9] similarly showed that obese
subjects with central fat distribution defined by an in-
creased waist-to-hip ratio (WHR ≥0.9 for men and ≥0.8
for women) had an increased risk of microalbuminuria
compared to obese subjects with a peripheral fat distri-
bution (WHR <0.9 for men and <0.8 for women). Further-
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Figure 1 Association between waist circumference (WC), waist-to-height ratio (WHtR) or body mass index (BMI) and uACR (upper panels)
or eGFR (lower panels) for the whole study population. Left side: Linear regression with restricted cubic splines. Right side: Adjusted mean uACR
and adjusted mean eGFR with 95% confidence intervals according to sex-specific quintiles of WC, WHtR or BMI calculated by analyses of variance. All
models were adjusted for age, sex, type 2 diabetes mellitus and hypertension.
Dittmann et al. BMC Nephrology 2013, 14:87 Page 4 of 7
http://www.biomedcentral.com/1471-2369/14/87
with a central fat distribution were at a higher risk of a
diminished GFR than subjects with a peripheral fat distri-
bution [9].
We also observed positive associations between high
WC, WHtR or BMI and the risk of CKD. These findings
confirm the results of a community-based, cross-sectional
study [15] that found a positive relationship between
WHtR and the risk of CKD. There was no association
between BMI and CKD in this study [15]. These results
support the conclusion that WC [6] and WHtR [15] are
more sensitive markers of CKD than BMI.
A study in 143 children with CKD [16] revealed that
advanced CKD was associated with a low lean leg mass,
indicating skeletal muscle wasting. Recent literature [17]
suggests that muscle wasting in the context of CKD may
be due to inflammation. Another study [18] showed that
patients with a relatively modest degree of CKD are
characterised by reduced lean body mass and bone
mineral content. These findings reveal the complex rela-
tionships between anthropometry, metabolism and renal
function and indicate that fat tissue measurement may
contribute to the detection of renal impairment.
Central obesity is frequently associated with risk factors
of CKD, such as hypertension [19,20] and type 2 diabetes
mellitus [20,21]. The PREVEND study [9] described
higher systolic and diastolic blood pressures in overweight
and obese subjects with a central fat distribution than in
subjects with a peripheral fat distribution. During the last
decades, adipose tissue has emerged as an active endo-
crine organ that releases several bioactive mediators,
modulating haemostasis, blood pressure, lipid and glucose
metabolism, inflammation and atherosclerosis [21]. There-
fore, our findings of an association between WHtR or
WC, as indices of central obesity [22], and the risk of
microalbuminuria argue for an important role for visceral
vs. peripheral fat in relation to albumin excretion.
Previous studies suggest that abdominal obesity may in-
dependently associate with microalbuminuria [9,14,23-27].
Data from the MONICA Augsburg survey 1994/95 [23]
showed that microalbuminuric subjects had a higher WC,
WHR and prevalence of elevated central adiposity and
obesity than subjects without microalbuminuria. Another
study [28] using measurements of visceral adipose tissue
(VAT) and subcutaneous adipose tissue (SAT) revealed
that VAT was associated with microalbuminuria in men
but not in women and showed that microalbuminuria
may represent a manifestation of visceral adiposity. How-
ever, our observation of an association between a low WC
and risk of microalbuminuria argues against that assump-
tion. Reason for these discrepancies might be the different
definitions of obesity as well as microalbuminuria. Obesity
might be based on WC, WHR, WHtR or BMI, which all
do not differentiate between VAT and SAT accumulation.
Furthermore, altered techniques used for the detection of
microalbuminuria resulting in a reported prevalence of
microalbuminuria ranging from 10% to 40% [29,30].
The pathophysiology underlying the association bet-
ween low anthropometry and microalbuminuria is yet
unknown. Which is partly part due to the fact that the
pathophysiology leads to the development of microal-
buminuria are not fully understood. The most likely
reason is an alteration of intrarenal hemodynamics and
may represent in hypertension as well as type 2 diabetes
mellitus as an early unspecific feature of renal impair-
ment. Even if the relation between low anthropometry
and microalbuminuria is not fully explained, it is widely
accepted that the association between BMI and all-cause
mortality was U-shaped with the lowest mortality
between 22.5-25 kg/m2 [31]. Thus a low or high BMI is
related to higher mortality risk. Furthermore, there is no
doubt that microalbuminuria is a valid biomarker of
increased mortality risk [32]. Therefore, microalbuminu-
ria in low values of anthropometry might reflect a
damage of glomerulus with complete different patho-
physiology compared to vascular risk burden, like hyper-
tension or diabetes, in obese people. There is good
evidence of epidemiological studies that lowering fetal
growth or low birth weight, result in an increased inci-
dence of hypertension or renal impairment when the
Table 2 Logistic regression models for the associations
between sex-specific quintiles of WC, WHtR or BMI and
microalbuminuria or CKD in the whole study population
(n = 3749)
Microalbuminuria CKD
OR (95% CI) p-value OR (95% CI) p-value
Waist circumference (WC) [cm]
I 1.48 (1.06; 2.06) 0.02 1.26 (0.75; 2.11) 0.38
II 1.14 (0.84; 1.55) 0.40 1.12 (0.73; 1.71) 0.60
III reference reference
IV 1.21 (0.91; 1.60) 0.18 1.19 (0.83; 1.71) 0.35
V 1.52 (1.16; 2.00) <0.01 1.63 (1.15; 2.32) <0.01
Waist-to-height ratio (WHtR)
I 1.20 (0.85; 1.71) 0.30 1.56 (0.87; 2.78) 0.14
II 0.91 (0.66; 1.24) 0.54 1.39 (0.89; 2.17) 0.14
III reference reference
IV 1.06 (0.80; 1.39) 0.69 1.18 (0.81; 1.72) 0.39
V 1.33 (1.03; 1.74) 0.03 1.83 (1.28; 2.60) <0.01
Body mass index (BMI) [kg/m2]
I 1.28 (0.94; 1.75) 0.11 0.92 (0.57; 1.48) 0.72
II 0.91 (0.68; 1.23) 0.56 0.86 (0.56; 1.31) 0.48
III reference reference
IV 1.01 (0.76; 1.33) 0.96 1.00 (0.70; 1.44) 0.99
V 1.16 (0.89; 1.53) 0.27 1.47 (1.04; 2.10) 0.03
CI = confidence interval; CKD = chronic kidney disease; OR = odds ratio.
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offspring reaches adulthood. One possible hypothesis
might be, that conditions affecting fetal development lead-
ing to low birth weight are associated with renal program-
ming or subclinical renal disease [33]. Microalbuminuria
in such people might be one biomarker of these condi-
tions, which is absolutely speculative at the moment.
In general, cross sectional epidemiological studies are
not suited to estimate pathophysiology and causality.
Therefore, further science, especially animals studies or
interventional trials are needed to investigate the
phenomenon of U-shaped association between microal-
buminuria and anthropometry in more detail.
Two limitations of our study merit special consi-
deration. First, due to the lack of longitudinal data, we
cannot detect causality between the anthropometric
measures and renal dysfunction. Second, instead of
complex and cost-intensive measurements of fat dis-
tribution, we used common measurements, such as
height, weight and WC to assess the relationship bet-
ween anthropometric parameters with renal dysfunction.
These parameters are easy to measure in clinical practice
and public health settings but may not be as accurate as
measuring body fat distribution.
Conclusions
Our data suggest that both a high and low WC or WHtR
and low BMI are associated with a higher uACR. Not only
subjects with a high WC or WHtR but also subjects with
a low WC may have an increased risk of microalbu-
minuria. However, our data provide no evidence that any
of the considered anthropometric parameters are associ-
ated with eGFR. Nevertheless, subjects with a high WC,
WHtR or BMI exhibit an increased risk of CKD compared
to subjects with average anthropometric values.
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